Hepatitis C virus diagnosis and therapeutic monitoring: Methods and interpretation

Clinical Microbiology Newsletter

Volumn 21, Issue 9, 1999, Pages 67-72

  Cook, Linda ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

BLOOD DONOR; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS C VIRUS; IMMUNOBLOTTING; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; STANDARDIZATION; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS GENE; VIRUS TRANSMISSION;

EID: 0033135874     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(00)80047-1     Document Type: Review

References (14)

1. Choo, Q.-L. et al. 1989. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
2. Brechot, C. 1996. Hepatitis C virus, molecular biology and genetic variability. Dig. Dis. Sci. 41:6S-21S
3. Buch, J., R.H. Miller, and R.H. Purcell. 1995. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Sem. Liver Dis. 15:441-463.
4. Alter, M.J. et al. 1992. The natural history of community-acquired hepatitis C in the United States. N. Eng. J. Med. 327:1899-1905.
5. Hadziyannis, S.J. 1996. Nonhepatic manifestations and combined diseases in HCV infection. Dig. Dis. Sci. 41:63S-74S.
6. Yuki, N. et al. 1993. Quantitative analysis of antibodies to hepatitis C virus during interferon-α therapy. Hepatology 17:960-965.
7. Papatheodoridis, G.V. et al. 1997. Significance of IgM anti-HCV core level in chronic hepatitis C. J. Hepatol. 27:36-41.
8. Lee, J.-H., W.K. Roth, and S. Zeuzem. 1997. Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays. J. Hepatol. 26:1001-1009.
9. Damen, M. et al. 1996. International collaborative study on the second EUROHEP HCV-RNA reference panel. J. Vir. Meth. 58:175-185.
10. Hawkins, A., F. Davidson, and P. Simmons. 1997. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay version 1 and 2, Roche Monitor assay, and in-house limiting dilution method. J. Clin. Microbiol. 35:187-192.
11. Recommendations for prevention and control of Hepatitis C virus (HCV) infection and HCV related chronic disease. MMWR 47 (RR-19):1-39, October 16, 1998.
12. Management of Hepatitis C, NIH consensus statement 1997, March 24-26, 15(3).
13. Medical devices; classification/reclassification; restricted devices, analyte-specific reagents 21CFR 809. Final rule. Federal Register 1997, 62:62243-62260.
14. FDA Regulations - Guidance for industry: supplemental testing and the notification of consignees of donor test results for antibody to Hepatitis C (Anti-HCV). Issued 20 March 1998.